The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells
Open accessAbstract
Connective tissue growth factor (CCN2) drives fibrogenesis in hepatic stellate cells (HSC). Here we show that CCN2 up-regulation in fibrotic or steatotic livers, or in culture-activated or ethanol-treated primary mouse HSC, is associated with a reciprocal down-regulation of microRNA-214 (miR-214). By using protector or reporter assays to investigate the 3′-untranslated region (UTR) of CCN2 mRNA, we found that induction of CCN2 expression in HSC by fibrosis-inducing stimuli was due to reduced expression of miR-214, which otherwise inhibited CCN2 expression by directly binding to the CCN2 3′-UTR. Additionally, miR-214 was present in HSC exosomes, which were bi-membrane vesicles, 50-150 nm in diameter, negatively charged (−26 mV), and positive for CD9. MiR-214 levels in exosomes but not in cell lysates were reduced by pretreatment of the cells with the exosome inhibitor, GW4869. Coculture of either quiescent HSC or miR-214-transfected activated HSC with CCN2 3′-UTR luciferase reporter-transfected recipient HSC resulted in miR-214- and exosome-dependent regulation of a wild-type CCN2 3′-UTR reporter but not of a mutant CCN2 3′-UTR reporter lacking the miR-214 binding site. Exosomes from HSC were a conduit for uptake of miR-214 by primary mouse hepatocytes. Down-regulation of CCN2 expression by miR-214 also occurred in human LX-2 HSC, consistent with a conserved miR-214 binding site in the human CCN2 3′-UTR. MiR-214 in LX-2 cells was shuttled by way of exosomes to recipient LX-2 cells or human HepG2 hepatocytes, resulting in suppression of CCN2 3′-UTR activity or expression of CCN2 downstream targets, including alpha smooth muscle actin or collagen. Experimental fibrosis in mice was associated with reduced circulating miR-214 levels. Conclusion: Exosomal transfer of miR-214 is a paradigm for the regulation of CCN2-dependent fibrogenesis and identifies fibrotic pathways as targets of intercellular regulation by exosomal miRs. (HEPATOLOGY 2014;59:1118–1129)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107821 · Cited by 1,934
Exosomes: secreted vesicles and intercellular communications
Théry, C. (2011) · F1000 Biology Reports · doi:10.3410/b3-15 · Cited by 989
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
Roderburg, C., Urban, G.-W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., et al. (2011) · Hepatology · doi:10.1002/hep.23922 · Cited by 803
Lipson, K. E., Wong, C., Teng, Y., & Spong, S. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 575
Xu, J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., Huang, L., Li, H., Tan, W., Wang, C., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20712 · Cited by 567
Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling
Chairoungdua, A., Smith, D. L., Pochard, P., Hull, M., & Caplan, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201002049 · Cited by 562
Kogure, T., Lin, W.-L., Yan, I. K., Braconi, C., & Patel, T. (2011) · Hepatology · doi:10.1002/hep.24504 · Cited by 551
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Tomimaru, Y., Eguchi, H., Nagano, H., Wada, H., Kobayashi, S., Marubashi, S., Tanemura, M., Tomokuni, A., Takemasa, I., Umeshita, K., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.026 · Cited by 361
Friedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350
Expression of connective tissue growth factor in experimental rat and human liver fibrosis
Paradis, V., Dargere, D., Vidaud, M., de Gouville, A.-C., Huet, S., Martinez, V., Gauthier, J.-M., Ba, N., Sobesky, R., Ratziu, V., et al. (1999) · Hepatology · doi:10.1002/hep.510300425 · Cited by 324
Masyuk, A. I., Huang, B. Q., Ward, C. J., Gradilone, S. A., Banales, J. M., Masyuk, T. V., Radtke, B., Splinter, P. L., & LaRusso, N. F. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00093.2010 · Cited by 285
Small RNAs have a large impact: Circulating microRNAs as biomarkers for human diseases
Weiland, M., Gao, X.-H., Zhou, L., & Mi, Q.-S. (2012) · RNA Biology · doi:10.4161/rna.20378 · Cited by 265
Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis
Rachfal, A. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00115-3 · Cited by 251
Proposal for a unified CCN nomenclature: Table 1
Brigstock, D. R., Goldschmeding, R., Katsube, K.-I., Lam, S. C.-T., Lau, L. F., Lyons, K., Naus, C., Perbal, B., Riser, B., Takigawa, M., et al. (2003) · Molecular Pathology · doi:10.1136/mp.56.2.127 · Cited by 250
Self-citationDolganiuc, A., Petrasek, J., Kodys, K., Catalano, D., Mandrekar, P., Velayudham, A., & Szabo, G. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01007.x · Cited by 191
Pan, Q., Ramakrishnaiah, V., Henry, S., Fouraschen, S., de Ruiter, P. E., Kwekkeboom, J., Tilanus, H. W., Janssen, H. L. A., & van der Laan, L. J. W. (2012) · Gut · doi:10.1136/gutjnl-2011-300449 · Cited by 164
microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis
Noetel, A., Kwiecinski, M., Elfimova, N., Huang, J., & Odenthal, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00049 · Cited by 157
Williams, E. J., Gaça, M., Brigstock, D. R., Arthur, M. J. P., & Benyon, R. C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80244-5 · Cited by 141
Self-citationRegulation of hepatic stellate cells by connective tissue growth factor
Huang, G., & Brigstock, D. R. (2012) · Frontiers in bioscience · doi:10.2741/4067 · Cited by 137
Self-citationBihrer, V., Waidmann, O., Friedrich‐Rust, M., Forestier, N., Süsser, S., Haupenthal, J., Welker, M., Shi, Y., Peveling‐Oberhag, J., Polta, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026971 · Cited by 135
Connective tissue growth factor in human liver cirrhosis
Abou-Shady, M. A., Friess, H., Zimmermann, A., di Mola, F. F., Guo, X., Baer, H. U., & Büchler, M. W. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020004296.x · Cited by 103
Advances in antifibrotic therapy
Ghiassi–Nejad, Z., & Friedman, S. L. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.6.803 · Cited by 85
A conserved noncoding intronic transcript at the mouse Dnm3 locus
Loebel, D. A. F., Tsoi, B., Wong, N., & Tam, P. (2005) · Genomics · doi:10.1016/j.ygeno.2005.02.001 · Cited by 81
Induction of microRNA-214-5p in human and rodent liver fibrosis
Iizuka, M., Ogawa, T., Enomoto, M., Motoyama, H., Yoshizato, K., Ikeda, K., & Kawada, N. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-12 · Cited by 81
Brigstock, D. R. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0043-9 · Cited by 69
Self-citationSerum microRNA Biomarkers for Drug-Induced Liver Injury
Lewis, P. J. S., Merz, M., Couttet, P., Grenet, O., Dear, J. W., Antoine, D. J., Goldring, C. E., Park, B. K., & Moggs, J. G. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.101 · Cited by 69
Circulating MicroRNA Is a Biomarker of Biliary Atresia
Zahm, A. M., Hand, N. J., Boateng, L. A., & Friedman, J. R. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318264e648 · Cited by 65
Chen, L., Charrier, A., Leask, A., French, S. W., & Brigstock, D. R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.025 · Cited by 55
Self-citationConnective tissue growth factor and progressive fibrosis in biliary atresia
Kobayashi, H., Hayashi, N., Hayashi, K., Yamataka, A., Lane, G. J., & Miyano, T. (2004) · Pediatric Surgery International · doi:10.1007/s00383-004-1254-z · Cited by 37
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C
Hora, C., Negro, F., Leandro, G., Oneta, C. M., Rubbia‐Brandt, L., Muellhaupt, B., Helbling, B., Malinverni, R., Gonvers, J., Dufour, J., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01608.x · Cited by 35
Cited by
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Kim, M. S., Haney, M. J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N. L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., et al. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.012 · Cited by 1,410
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894
Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.005 · Cited by 704
Kim, M. S., Haney, M. J., Zhao, Y., Yuan, D., Deygen, I., Klyachko, N. L., Kabanov, A. V., & Batrakova, E. V. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.09.011 · Cited by 663
Metadata
- Authors
- Chen, L., Charrier, A., Zhou, Y., Chen, R., Yu, B., Agarwal, K., Tsukamoto, H., Lee, J. L., Paulaitis, M. E., & Brigstock, D. R.
- Venue
- Hepatology
- Published
- 2014-03
- Volume
- 59
- Issue
- 3
- Pages
- 1118-1129
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2062410076
- Cited by
- 264
- References
- 31
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.